会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 151. 发明申请
    • Modular battery management apparatus with cell sensing and energy redistribution capabilities
    • 具有电池感测和能量再分配功能的模块化电池管理设备
    • US20060193095A1
    • 2006-08-31
    • US10528897
    • 2003-09-24
    • Phillip HunterTimothy JohnsonDarren LimAdnan Anbuky
    • Phillip HunterTimothy JohnsonDarren LimAdnan Anbuky
    • H02H3/00
    • H02J7/0019H02J7/0021
    • A battery management system includes a sensing module, a feeding module, a control module, and a common line adapted for connection to a battery when in use. In some embodiments, a battery management apparatus for managing a substring of cells in a string of cells includes a DC bus, a multiplexer/demultiplexer circuit operative to selectively couple nodes of the substring of cells to the DC bus, a DC/DC converter circuit having a first port configured to be coupled across a plurality of cells of the string and a second port coupled to the DC bus, the DC/DC converter operative to transfer energy between the first and second ports, a sensor circuit coupled to the DC bus, and a controller circuit configured to connect to a communications bus and operatively associated with the multiplexer/demultiplexer circuit, the DC/DC converter and the sensor circuit.
    • 电池管理系统包括感测模块,馈送模块,控制模块和适于在使用时连接到电池的公共线路。 在一些实施例中,用于管理单元串中的单元的子串的电池管理装置包括DC总线,可操作以选择性地将单元子串的节点耦合到DC总线的多路复用器/解复用器电路,DC / DC转换器电路 具有配置成耦合在所述串的多个单元上的第一端口和耦合到所述DC总线的第二端口,所述DC / DC转换器用于在所述第一和第二端口之间传输能量,所述DC / DC转换器耦合到所述DC总线 以及控制器电路,被配置为连接到通信总线并且可操作地与多路复用器/解复用器电路,DC / DC转换器和传感器电路相关联。
    • 155. 发明申请
    • HIV integrase inhibitors
    • HIV整合酶抑制剂
    • US20050043370A1
    • 2005-02-24
    • US10919888
    • 2004-08-17
    • Michael WalkerTimothy JohnsonNicholas MeanwellJacques Banville
    • Michael WalkerTimothy JohnsonNicholas MeanwellJacques Banville
    • C07D213/40C07D307/52C07D317/40C07D317/58C07D333/58C07D405/12C07D407/12C07D213/26A61K31/137A61K31/335
    • C07D213/40C07D307/52C07D317/40C07D317/58C07D333/58C07D405/12C07D407/12
    • The present invention relates to the inhibition of HIV integrase, and to the treatment of AIDS or ARC by administering compounds of the formula wherein R1 is C1-C4 alkyl, carbocyclic radical, heterocyclic radical, aryl-C1-C2 alkylene, aryloxy-C1-C2 alkylene, alkoxy-CC(O)—, wherein R1 is optionally substituted from 1-3 times with halo, C1-C2 alkyl or C1-C2 alkoxy, or R1 is H; R2 is H or C1-C4 alkyl; R3 is H, C1-C4 alkyl or phenyl-C0-C2 alkylene which is optionally substituted with 1-3 R5; R4a is carbocylic radical, heterocyclic radical, aryloxy, aryl-C1-C4 alkylene, aryl-cyclopropylene, aryl-NHC(O)—, wherein R4a is optionally substituted with 1-3 R5; and wherein each R5 is independently selected from H, halo, C1-C4 alkyl, C1-C4 alkenyl, C1-C4 haloalkyl, C1-C4 alkoxy, R6-phenyl, R6-phenoxy, R6-benzyl, R6-benzyloxy, NH2C (O)-, alkyl-NHC(O)—, wherein R6 is H, halo; Z is a bond or a substituted or unsubstituted C1-C4 alkylene group; and B2 is
    • 本发明涉及HIV整合酶的抑制,以及通过给予下式化合物治疗AIDS或ARC的方法:其中R 1是C 1 -C 4烷基,碳环基,杂环基,芳基-C 1 -C 2亚烷基,芳氧基 -C 1 -C 2亚烷基,烷氧基-C(O) - ,其中R 1任选地被卤素,C 1 -C 2烷基或C 1 -C 2烷氧基取代1-3次,或者R 1是H; R 2是H或C 1 -C 4烷基; R 3是任选被1-3个R 5取代的H,C 1 -C 4烷基或苯基-C 0 -C 2亚烷基; R 4a是碳环基,杂环基,芳氧基,芳基-C 1 -C 4亚烷基,芳基 - 环丙基,芳基-NHC(O) - ,其中R 4a任选被1-3个R 5取代; 并且其中每个R 5独立地选自H,卤素,C 1 -C 4烷基,C 1 -C 4烯基,C 1 -C 4卤代烷基,C 1 -C 4烷氧基,R 6 - 苯基,R 6 - 苯氧基,R C 6 - 苄基,R 6 - 苄氧基,NH 2 C(O) - ,烷基-NHC(O) - ,其中R 6是H,卤素; Z是键或取代或未取代的C 1 -C 4亚烷基; 和B <2>是
    • 160. 发明授权
    • Process for manufacturing sized glass strands
    • 制造尺寸规格的玻璃丝的工艺
    • US5698000A
    • 1997-12-16
    • US354822
    • 1994-12-08
    • Patrick MoireauTimothy Johnson
    • Patrick MoireauTimothy Johnson
    • C03C25/10C03C25/26C08K7/00C08K7/02C08L57/00C08L101/00C03C25/02C03B37/10
    • C03C25/26Y10T428/2936Y10T428/2938Y10T428/2962Y10T428/2964
    • The invention relates to a process for manufacturing continuous a glass fiber strand. The process consists in depositing on the glass filaments which are in the process of being drawn a sizing composition of which the solvent content is less than 5 wt % of solvent selected from organic solvent and water, the solution comprising at least 70 wt % of a mixture of constituents which can be polymerized and/or crosslinked by heat treatment, at least 60 wt % of the constituents being constituents of which the molecular weight (Mw) is less than 750, less than 10 weight % being film-forming agents and 0 to 25 weight % being coupling agents, lubricants, stabilizers and initiators and/or catalysts, and in winding the strand or strands, formed by collection of the filaments, on a rotating support so as to form a wound package consisting of turns of strand coated with a non-polymerized sizing composition. The strands are intended to reinforce thermoplastic or thermosetting organic substrates or substances of mineral origin.
    • 本发明涉及连续玻璃纤维束的制造方法。 该方法包括沉积在正在拉伸其中溶剂含量小于5重量%的选自有机溶剂和水的溶剂的施胶组合物的过程中的玻璃纤维,该溶液包含至少70重量%的 可以通过热处理聚合和/或交联的组分的混合物,至少60重量%的组分是分子量(Mw)小于750,小于10重量%的成分是成膜剂和0 至25重量%为偶联剂,润滑剂,稳定剂和引发剂和/或催化剂,并且将通过收集长丝形成的链或股线卷绕在旋转的载体上,以便形成由缠绕的线 与未聚合的施胶组合物。 股线旨在加强热塑性或热固性有机基底或矿物来源的物质。